Skip to content
Novavax, a biotech company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced the initiation of a phase 2 trial for […]
Novavax announces phase 2 trial for combined COVID/flu vaccine Read More »
With an alarming global inflation rate and businesses generating lower revenues, the economic situation is also affecting biotech investment. But biotech is one industry
Biotech might beat inflation, offer hope for investors Read More »
Study the past, if you would define the future, Confucius once said. Staying true to this maxim, researchers delving deeper into the secrets of
2-million-year-old DNA could show solutions to future climate challenges Read More »
Vertex Pharmaceuticals Incorporated and Entrada Therapeutics, Inc. have formed a global partnership to find and develop treatments for myotonic dystrophy type 1 (DM1), a
Vertex partners with Entrada on new approach for muscle dystrophy treatment Read More »
Rolls-Royce and Gulfstream Aerospace Corp. are conducting the first original equipment manufacturer test flight of an ultralong-range business jet powered by 100% sustainable aviation
Rolls-Royce introduces new business jet powered by 100% SAF Read More »
Racism and inequities are among the key reasons behind the relatively high rates of Alzheimer’s disease and dementia-related diseases among non-white Americans, says a
HHS: Alzheimer’s risk linked to systemic racism Read More »
Thanks for joining us in Year 1 of Bio.News. We published over 700 stories in less than one year – and these were the
Our Top 15 Most-Clicked Stories of 2022 Read More »
The Centers for Disease Control and Prevention (CDC) said updated COVID-19 booster vaccines have improved Americans’ resistance against severe COVID, lowering the probability of
Updated COVID boosters slash hospitalization risk by 50% Read More »
The U.S. Food and Drug Administration (FDA) approved Genentech’s Actemra to treat COVID-19 in hospitalized adults. The drug is approved for adults “receiving systemic
FDA approves first monoclonal antibody to treat COVID-19 Read More »
The United States and the Biotechnology Innovation Organization (BIO) have been taking action in light of ongoing negotiations concerning extending the Trade-Related Aspects of
What’s happening with the COVID IP waiver expansion? Read More »
